Eli Lilly and Company
CHMP positive opinion granted for two cancer indications
Published in Pharma Investments, Ventures and Law Weekly, July 25th, 2004
The CHMP has recommended to the European Commission that approval be granted for pemetrexed. If approved, this cancer therapy will be marketed throughout the European Union by Lilly under the brand name Alimta (pemetrexed). Marketing authorization by the European Commission is expected later this year.
If approved, pemetrexed, in combination with cisplatin, will be the first approved drug in Europe to help patients with malignant pleural mesothelioma live longer and, as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- A.P. Pharma, Inc.
Pharmaceutical company completes common stock sale - ATS Medical, Inc.
Device firm signs definitive agreements to sell $13.1M of common stock - Abaxis, Inc.
Blood analysis systems maker to be added to Russell 2000 Index - Accumetrics, Inc.
Diagnostics company announces $13.5M financing - Aeolus Pharmaceuticals, Inc.
Incara announces 1-for-10 reverse split and name change - Alaris Medical Systems
ICU Medical announces court order in patent infringement lawsuit - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
